ABBV
Abbvie Inc
Price:  
157.06 
USD
Volume:  
3,689,986.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Abbvie Relative Valuation

-26.4%
Upside

As of 2024-05-26, the Relative Valuation of Abbvie Inc (ABBV) is 115.64 USD. This relative valuation is based on P/E multiples. With the latest stock price at 157.06 USD, the upside of Abbvie Inc based on Relative Valuation is -26.4%.

The range of the Relative Valuation is 101.21 - 151.43 USD.

Range Selected
Trailing P/E multiples 32.1x - 44.6x 37.9x
Forward P/E multiples 28.2x - 40.8x 28.6x
Fair Price 101.21 - 151.43 115.64
Upside -35.6% - -3.6% -26.4%
157.06 USD
Stock Price
115.64 USD
Fair Price

Abbvie Relative Valuation - Historical P/E Data

Date P/E
2024-05-24 46.28
2024-05-23 46.63
2024-05-22 47.03
2024-05-21 48.01
2024-05-20 48.49
2024-05-17 49.04
2024-05-16 48.43
2024-05-15 48.26
2024-05-14 47.61
2024-05-13 47.52
2024-05-10 47.37
2024-05-09 47.26
2024-05-08 47.28
2024-05-07 47.90
2024-05-06 47.95
2024-05-03 48.26
2024-05-02 47.38
2024-05-01 47.65
2024-04-30 47.92
2024-04-29 47.59
2024-04-26 47.03
2024-04-25 49.29
2024-04-24 49.44
2024-04-23 49.96
2024-04-22 49.47
2024-04-19 49.03
2024-04-18 48.52
2024-04-17 48.40
2024-04-16 47.89
2024-04-15 47.64
2024-04-12 47.82
2024-04-11 49.36
2024-04-10 49.81
2024-04-09 50.13
2024-04-08 50.03
2024-04-05 50.09
2024-04-04 49.47
2024-04-03 52.25
2024-04-02 53.24
2024-04-01 53.26
2024-03-28 53.66
2024-03-27 53.14
2024-03-26 52.80
2024-03-25 52.60
2024-03-22 52.58
2024-03-21 52.30
2024-03-20 51.94
2024-03-19 52.94
2024-03-18 52.59
2024-03-15 52.41